 | • レポートコード：QY20ST-03716 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：機械・装置 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の二重特異性抗体治療市場について種類別（Fcリージョンベアリング、Fcリージョン欠如）、用途別（骨学、肺、呼吸器疾患、腫瘍学、遺伝子治療）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・二重特異性抗体治療市場の概要 ・世界の主要地域別二重特異性抗体治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の二重特異性抗体治療市場規模2015-2026：種類別（Fcリージョンベアリング、Fcリージョン欠如） ・世界の二重特異性抗体治療市場規模2015-2026：用途別（骨学、肺、呼吸器疾患、腫瘍学、遺伝子治療） ・二重特異性抗体治療の北米市場規模2015-2020 ・二重特異性抗体治療のヨーロッパ市場規模2015-2020 ・二重特異性抗体治療の中国市場規模2015-2020 ・二重特異性抗体治療の日本市場規模2015-2020 ・二重特異性抗体治療の東南アジア市場規模2015-2020 ・二重特異性抗体治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・二重特異性抗体治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・二重特異性抗体治療の市場動向・機会・課題 ・調査の結論 |
Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads to targeted sites. The approval of catumaxomab (anti-EpCAM and anti-CD3) and blinatumomab (anti-CD19 and anti-CD3) has become a major milestone in the development of bsAbs. Currently, more than 60 different bsAb formats exist, some of them making their way into the clinical pipeline. This review summarizes diverse formats of bsAbs and their clinical applications and sheds light on strategies to optimize the design of bsAbs.
Market Analysis and Insights: Global Bispecific Antibody Therapeutic Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Bispecific Antibody Therapeutic market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Bispecific Antibody Therapeutic industry.
Based on our recent survey, we have several different scenarios about the Bispecific Antibody Therapeutic YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Bispecific Antibody Therapeutic will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Bispecific Antibody Therapeutic Scope and Market Size
The global Bispecific Antibody Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bispecific Antibody Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bispecific Antibody Therapeutic market is segmented into
Bearing An Fc Region
Lacking An Fc Region
Segment by Application, the Bispecific Antibody Therapeutic market is segmented into
Osteology
Pulmonary
Respiratory Diseases
Oncology
Gene Therapy
The Bispecific Antibody Therapeutic market is analysed and market size information is provided by regions (countries). Segment by Application, the Bispecific Antibody Therapeutic market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bispecific Antibody Therapeutic Market Share Analysis
Bispecific Antibody Therapeutic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bispecific Antibody Therapeutic business, the date to enter into the Bispecific Antibody Therapeutic market, Bispecific Antibody Therapeutic product introduction, recent developments, etc.
The major vendors covered:
Creative-biolabs
PharmAbcine
Sorrento Therapeutics
Patheon
…
1 Bispecific Antibody Therapeutic Market Overview
1.1 Bispecific Antibody Therapeutic Product Scope
1.2 Bispecific Antibody Therapeutic Segment by Type
1.2.1 Global Bispecific Antibody Therapeutic Sales by Type (2020-2026)
1.2.2 Bearing An Fc Region
1.2.3 Lacking An Fc Region
1.3 Bispecific Antibody Therapeutic Segment by Application
1.3.1 Global Bispecific Antibody Therapeutic Sales Comparison by Application (2020-2026)
1.3.2 Osteology
1.3.3 Pulmonary
1.3.4 Respiratory Diseases
1.3.5 Oncology
1.3.6 Gene Therapy
1.4 Bispecific Antibody Therapeutic Market Estimates and Forecasts (2015-2026)
1.4.1 Global Bispecific Antibody Therapeutic Sales Growth Rate (2015-2026)
1.4.2 Global Bispecific Antibody Therapeutic Revenue and Growth Rate (2015-2026)
1.4.3 Global Bispecific Antibody Therapeutic Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Bispecific Antibody Therapeutic Industry Impact
1.5.1 How the Covid-19 is Affecting the Bispecific Antibody Therapeutic Industry
1.5.1.1 Bispecific Antibody Therapeutic Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Bispecific Antibody Therapeutic Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Bispecific Antibody Therapeutic Players to Combat Covid-19 Impact
2 Bispecific Antibody Therapeutic Estimate and Forecast by Region
2.1 Global Bispecific Antibody Therapeutic Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Bispecific Antibody Therapeutic Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Bispecific Antibody Therapeutic Sales Market Share by Region (2015-2020)
2.2.2 Global Bispecific Antibody Therapeutic Revenue Market Share by Region (2015-2020)
2.3 Global Bispecific Antibody Therapeutic Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Bispecific Antibody Therapeutic Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Bispecific Antibody Therapeutic Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Bispecific Antibody Therapeutic Estimates and Projections (2015-2026)
2.4.2 Europe Bispecific Antibody Therapeutic Estimates and Projections (2015-2026)
2.4.3 China Bispecific Antibody Therapeutic Estimates and Projections (2015-2026)
2.4.4 Japan Bispecific Antibody Therapeutic Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Bispecific Antibody Therapeutic Estimates and Projections (2015-2026)
2.4.6 India Bispecific Antibody Therapeutic Estimates and Projections (2015-2026)
3 Global Bispecific Antibody Therapeutic Competition Landscape by Players
3.1 Global Top Bispecific Antibody Therapeutic Players by Sales (2015-2020)
3.2 Global Top Bispecific Antibody Therapeutic Players by Revenue (2015-2020)
3.3 Global Bispecific Antibody Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bispecific Antibody Therapeutic as of 2019)
3.4 Global Bispecific Antibody Therapeutic Average Price by Company (2015-2020)
3.5 Manufacturers Bispecific Antibody Therapeutic Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Bispecific Antibody Therapeutic Players (Opinion Leaders)
4 Global Bispecific Antibody Therapeutic Market Size by Type
4.1 Global Bispecific Antibody Therapeutic Historic Market Review by Type (2015-2020)
4.1.1 Global Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
4.1.2 Global Bispecific Antibody Therapeutic Revenue Market Share by Type (2015-2020)
4.1.3 Global Bispecific Antibody Therapeutic Price by Type (2014-2020)
4.2 Global Bispecific Antibody Therapeutic Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Bispecific Antibody Therapeutic Sales Forecast by Type (2021-2026)
4.2.2 Global Bispecific Antibody Therapeutic Revenue Forecast by Type (2021-2026)
4.2.3 Global Bispecific Antibody Therapeutic Price Forecast by Type (2021-2026)
5 Global Bispecific Antibody Therapeutic Market Size by Application
5.1 Global Bispecific Antibody Therapeutic Historic Market Review by Application (2015-2020)
5.1.1 Global Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
5.1.2 Global Bispecific Antibody Therapeutic Revenue Market Share by Application (2015-2020)
5.1.3 Global Bispecific Antibody Therapeutic Price by Application (2015-2020)
5.2 Global Bispecific Antibody Therapeutic Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Bispecific Antibody Therapeutic Sales Forecast by Application (2021-2026)
5.2.2 Global Bispecific Antibody Therapeutic Revenue Forecast by Application (2021-2026)
5.2.3 Global Bispecific Antibody Therapeutic Price Forecast by Application (2021-2026)
3 North America Bispecific Antibody Therapeutic Market Facts & Figures
3.2 North America Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
3.3 North America Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
3.4 North America Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
4 Europe Bispecific Antibody Therapeutic Market Facts & Figures
4.2 Europe Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
4.3 Europe Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
4.4 Europe Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
5 China Bispecific Antibody Therapeutic Market Facts & Figures
5.2 China Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
5.3 China Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
5.4 China Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
6 Japan Bispecific Antibody Therapeutic Market Facts & Figures
6.2 Japan Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
6.3 Japan Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
6.4 Japan Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
7 Southeast Asia Bispecific Antibody Therapeutic Market Facts & Figures
7.2 Southeast Asia Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
8 India Bispecific Antibody Therapeutic Market Facts & Figures
8.2 India Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
8.3 India Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
8.4 India Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Bispecific Antibody Therapeutic Business
12.1 Creative-biolabs
12.1.1 Creative-biolabs Bispecific Antibody Therapeutic Corporation Information
12.1.2 Creative-biolabs Bispecific Antibody Therapeutic Business Overview and Total Revenue
12.1.3 Creative-biolabs Bispecific Antibody Therapeutic Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Creative-biolabs Bispecific Antibody Therapeutic Products Offered
12.1.5 Creative-biolabs Recent Development
12.2 PharmAbcine
12.2.1 PharmAbcine Bispecific Antibody Therapeutic Corporation Information
12.2.2 PharmAbcine Bispecific Antibody Therapeutic Business Overview and Total Revenue
12.2.3 PharmAbcine Bispecific Antibody Therapeutic Sales, Revenue and Gross Margin (2015-2020)
12.2.4 PharmAbcine Bispecific Antibody Therapeutic Products Offered
12.2.5 PharmAbcine Recent Development
12.3 Sorrento Therapeutics
12.3.1 Sorrento Therapeutics Bispecific Antibody Therapeutic Corporation Information
12.3.2 Sorrento Therapeutics Bispecific Antibody Therapeutic Business Overview and Total Revenue
12.3.3 Sorrento Therapeutics Bispecific Antibody Therapeutic Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sorrento Therapeutics Bispecific Antibody Therapeutic Products Offered
12.3.5 Sorrento Therapeutics Recent Development
12.4 Patheon
12.4.1 Patheon Bispecific Antibody Therapeutic Corporation Information
12.4.2 Patheon Bispecific Antibody Therapeutic Business Overview and Total Revenue
12.4.3 Patheon Bispecific Antibody Therapeutic Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Patheon Bispecific Antibody Therapeutic Products Offered
12.4.5 Patheon Recent Development
…
13 Bispecific Antibody Therapeutic Manufacturing Cost Analysis
13.1 Bispecific Antibody Therapeutic Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bispecific Antibody Therapeutic
13.4 Bispecific Antibody Therapeutic Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bispecific Antibody Therapeutic Distributors List
14.3 Bispecific Antibody Therapeutic Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Bispecific Antibody Therapeutic Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Bispecific Antibody Therapeutic Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Bispecific Antibody Therapeutic Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Bispecific Antibody Therapeutic Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Bispecific Antibody Therapeutic Players to Combat Covid-19 Impact
Table 8. Global Market Bispecific Antibody Therapeutic Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Bispecific Antibody Therapeutic Sales (K Units) by Region (2015-2020)
Table 10. Global Bispecific Antibody Therapeutic Sales Market Share by Region (2015-2020)
Table 11. Global Bispecific Antibody Therapeutic Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Bispecific Antibody Therapeutic Revenue Share by Region (2015-2020)
Table 13. Global Bispecific Antibody Therapeutic Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Bispecific Antibody Therapeutic Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Bispecific Antibody Therapeutic Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Bispecific Antibody Therapeutic Revenue Share Forecast by Region (2021-2026)
Table 17. Global Bispecific Antibody Therapeutic (K Units) of Key Companies (2015-2020)
Table 18. Global Bispecific Antibody Therapeutic Sales Share by Company (2015-2020)
Table 19. Global Bispecific Antibody Therapeutic Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Bispecific Antibody Therapeutic Revenue Share by Company (2015-2020)
Table 21. Global Bispecific Antibody Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bispecific Antibody Therapeutic as of 2019)
Table 22. Global Bispecific Antibody Therapeutic Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Bispecific Antibody Therapeutic Manufacturing Sites and Area Served
Table 24. Manufacturers Bispecific Antibody Therapeutic Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Bispecific Antibody Therapeutic Players
Table 27. Global Bispecific Antibody Therapeutic Sales (K Units) by Type (2015-2020)
Table 28. Global Bispecific Antibody Therapeutic Sales Share by Type (2015-2020)
Table 29. Global Bispecific Antibody Therapeutic Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Bispecific Antibody Therapeutic Price (K Units) by Type (2015-2020)
Table 31. Global Bispecific Antibody Therapeutic Sales Share by Type (2021-2026)
Table 32. Global Bispecific Antibody Therapeutic Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Bispecific Antibody Therapeutic Revenue Share by Type (2021-2026)
Table 34. Global Bispecific Antibody Therapeutic Price (K Units) by Type (2021-2026)
Table 35. Global Bispecific Antibody Therapeutic Sales (K Units) by Application (2015-2020)
Table 36. Global Bispecific Antibody Therapeutic Sales Share by Application (2015-2020)
Table 37. Global Bispecific Antibody Therapeutic Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Bispecific Antibody Therapeutic Price (K Units) by Application (2015-2020)
Table 39. Global Bispecific Antibody Therapeutic Sales (K Units) by Application (2021-2026)
Table 40. Global Bispecific Antibody Therapeutic Sales Share by Application (2021-2026)
Table 41. Global Bispecific Antibody Therapeutic Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Bispecific Antibody Therapeutic Revenue Share by Application (2021-2026)
Table 43. Global Bispecific Antibody Therapeutic Price (K Units) by Application (2021-2026)
Table 44. United States Bispecific Antibody Therapeutic Sales (K Units) by Company (2015-2020)
Table 45. United States Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
Table 46. United States Bispecific Antibody Therapeutic Sales (K Units) by Type (2015-2020)
Table 47. United States Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
Table 48. United States Bispecific Antibody Therapeutic Sales (K Units) by Application (2015-2020)
Table 49. United States Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
Table 50. Europe Bispecific Antibody Therapeutic Sales (K Units) by Company (2015-2020)
Table 51. Europe Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
Table 52. Europe Bispecific Antibody Therapeutic Sales (K Units) by Type (2015-2020)
Table 53. Europe Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
Table 54. Europe Bispecific Antibody Therapeutic Sales (K Units) by Application (2015-2020)
Table 55. Europe Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
Table 56. China Bispecific Antibody Therapeutic Sales (K Units) by Company (2015-2020)
Table 57. China Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
Table 58. China Bispecific Antibody Therapeutic Sales (K Units) by Type (2015-2020)
Table 59. China Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
Table 60. China Bispecific Antibody Therapeutic Sales (K Units) by Application (2015-2020)
Table 61. China Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
Table 62. Japan Bispecific Antibody Therapeutic Sales (K Units) by Company (2015-2020)
Table 63. Japan Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
Table 64. Japan Bispecific Antibody Therapeutic Sales (K Units) by Type (2015-2020)
Table 65. Japan Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
Table 66. Japan Bispecific Antibody Therapeutic Sales (K Units) by Application (2015-2020)
Table 67. Japan Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Bispecific Antibody Therapeutic Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Bispecific Antibody Therapeutic Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Bispecific Antibody Therapeutic Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
Table 74. India Bispecific Antibody Therapeutic Sales (K Units) by Company (2015-2020)
Table 75. India Bispecific Antibody Therapeutic Sales Market Share by Company (2015-2020)
Table 76. India Bispecific Antibody Therapeutic Sales (K Units) by Type (2015-2020)
Table 77. India Bispecific Antibody Therapeutic Sales Market Share by Type (2015-2020)
Table 78. India Bispecific Antibody Therapeutic Sales (K Units) by Application (2015-2020)
Table 79. India Bispecific Antibody Therapeutic Sales Market Share by Application (2015-2020)
Table 80. Creative-biolabs Corporation Information
Table 81. Creative-biolabs Description and Business Overview
Table 82. Creative-biolabs Bispecific Antibody Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Creative-biolabs Bispecific Antibody Therapeutic Product
Table 84. Creative-biolabs Recent Development
Table 85. PharmAbcine Corporation Information
Table 86. PharmAbcine Description and Business Overview
Table 87. PharmAbcine Bispecific Antibody Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. PharmAbcine Bispecific Antibody Therapeutic Product
Table 89. PharmAbcine Recent Development
Table 90. Sorrento Therapeutics Corporation Information
Table 91. Sorrento Therapeutics Description and Business Overview
Table 92. Sorrento Therapeutics Bispecific Antibody Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Sorrento Therapeutics Bispecific Antibody Therapeutic Product
Table 94. Sorrento Therapeutics Recent Development
Table . Patheon Corporation Information
Table . Patheon Description and Business Overview
Table . Patheon Bispecific Antibody Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Patheon Bispecific Antibody Therapeutic Product
Table . Patheon Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Bispecific Antibody Therapeutic Distributors List
Table 103. Bispecific Antibody Therapeutic Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Bispecific Antibody Therapeutic Product Picture
Figure 2. Global Bispecific Antibody Therapeutic Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bispecific Antibody Therapeutic Market Share by Application in 2020 & 2026
Figure 6. Osteology Examples
Figure 7. Pulmonary Examples
Figure 8. Respiratory Diseases Examples
Figure 9. Oncology Examples
Figure 10. Gene Therapy Examples
Figure 11. Global Bispecific Antibody Therapeutic Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Bispecific Antibody Therapeutic Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Bispecific Antibody Therapeutic Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Bispecific Antibody Therapeutic Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Bispecific Antibody Therapeutic Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Bispecific Antibody Therapeutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Bispecific Antibody Therapeutic Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Bispecific Antibody Therapeutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Bispecific Antibody Therapeutic Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Bispecific Antibody Therapeutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Bispecific Antibody Therapeutic Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Bispecific Antibody Therapeutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Bispecific Antibody Therapeutic Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Bispecific Antibody Therapeutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Bispecific Antibody Therapeutic Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Bispecific Antibody Therapeutic Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Bispecific Antibody Therapeutic Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Bispecific Antibody Therapeutic Players Market Share by Revenue in Bispecific Antibody Therapeutic 2015 & 2019
Figure 29. Bispecific Antibody Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Bispecific Antibody Therapeutic Revenue Share by Type (2015-2020)
Figure 31. Global Bispecific Antibody Therapeutic Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Bispecific Antibody Therapeutic Revenue Share by Application (2015-2020)
Figure 33. Global Bispecific Antibody Therapeutic Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Bispecific Antibody Therapeutic Sales Market Share by Type in 2019
Figure 35. United States Bispecific Antibody Therapeutic Sales Market Share by Type in 2019
Figure 36. Europe Bispecific Antibody Therapeutic Sales Market Share by Company in 2019
Figure 37. Europe Bispecific Antibody Therapeutic Sales Market Share by Type in 2019
Figure 38. Europe Bispecific Antibody Therapeutic Sales Market Share by Application in 2019
Figure 39. China Bispecific Antibody Therapeutic Sales Market Share by Company in 2019
Figure 40. China Bispecific Antibody Therapeutic Sales Market Share by Type in 2019
Figure 41. China Bispecific Antibody Therapeutic Sales Market Share by Application in 2019
Figure 42. Japan Bispecific Antibody Therapeutic Sales Market Share by Company in 2019
Figure 43. Japan Bispecific Antibody Therapeutic Sales Market Share by Type in 2019
Figure 44. Japan Bispecific Antibody Therapeutic Sales Market Share by Application in 2019
Figure 45. Southeast Asia Bispecific Antibody Therapeutic Sales Market Share by Company in 2019
Figure 46. Southeast Asia Bispecific Antibody Therapeutic Sales Market Share by Type in 2019
Figure 47. Southeast Asia Bispecific Antibody Therapeutic Sales Market Share by Application in 2019
Figure 48. India Bispecific Antibody Therapeutic Sales Market Share by Company in 2019
Figure 49. India Bispecific Antibody Therapeutic Sales Market Share by Type in 2019
Figure 50. India Bispecific Antibody Therapeutic Sales Market Share by Application in 2019
Figure 51. Creative-biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. PharmAbcine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sorrento Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Patheon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Bispecific Antibody Therapeutic
Figure 57. Manufacturing Process Analysis of Bispecific Antibody Therapeutic
Figure 58. Bispecific Antibody Therapeutic Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
抗体生産サービスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Antibody Production Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibody Product…- 抗体生産サービスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Antibody Production Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibody Product…
- 抗HA抗体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global anti-HA Antibody market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The anti-HA Antibody market repo…
- 抗体医薬品の世界市場レポート2020 Market Analysis and Insights: Global Antibody Drugs Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019…
- 抗体アイソタイピングキットの世界市場レポート2020 A recently published report by QY Research titled Global Antibody Isotyping Kit Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…